| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |